MAM
GBT

Meeder Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Meeder Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19
Closed – – 2526
2021
Q3 		$0 Hold
19
– – ﹤0.01% 2707
2021
Q2 		$1K Hold
19
– – ﹤0.01% 2435
2021
Q1 		$1K Hold
19
– – ﹤0.01% 2297
2020
Q4 		$1K Hold
19
– – ﹤0.01% 1785
2020
Q3 		$1K Buy
+19
New +$1.21K ﹤0.01% 2085
2020
Q2 		– Sell
-40
Closed -$2K – 2617
2020
Q1 		$2K Sell
40
-8
-17% -$536 ﹤0.01% 2138
2019
Q4 		$4K Buy
48
+8
+20% +$474 ﹤0.01% 1878
2019
Q3 		$2K Hold
40
– – ﹤0.01% 2014
2019
Q2 		$2K Hold
40
– – ﹤0.01% 1902
2019
Q1 		$2K Sell
40
-275
-87% -$13.5K ﹤0.01% 1592
2018
Q4 		$13K Buy
+315
New +$11.8K ﹤0.01% 1178
2018
Q3 		– Sell
-137
Closed -$6.19K – 1739
2018
Q2 		$6.19K Sell
137
-516
-79% -$23.5K ﹤0.01% 1222
2018
Q1 		$32K Buy
653
+556
+573% +$31K ﹤0.01% 773
2017
Q4 		$4K Buy
97
+36
+59% +$1.34K ﹤0.01% 1394
2017
Q3 		$2K Sell
61
-144
-70% -$4.05K ﹤0.01% 1498
2017
Q2 		$6K Buy
205
+59
+40% +$1.76K ﹤0.01% 1159
2017
Q1 		$5K Sell
146
-490
-77% -$12.3K ﹤0.01% 1112
2016
Q4 		$9K Buy
+636
New +$11.2K ﹤0.01% 779

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Meeder Asset Management's GBT Position: Q4 2021 in Review

Meeder Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2021, closing a stake of 19 shares.

Meeder Asset Management first reported a position in GBT in Q4 2016 and held it in 18 quarters. The position peaked at $32K in Q1 2018. 206 funds tracked by Wall St. Rank hold GBT as of Q4 2021.

  • Meeder Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Meeder Asset Management sold 19 Global Blood Therapeutics, Inc. shares in Q4 2021.
  • Meeder Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 18 quarters.
  • Meeder Asset Management's Global Blood Therapeutics, Inc. position peaked at $32K in Q1 2018.
  • 206 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2021.

Based on Meeder Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.